State-level reforms

• Oregon's regulated access program and psilocybin decriminalization: AP News, Oregon.gov, Oregon State Legislature (.gov), www.shannonpowelllaw.com

• Colorado's decriminalization of psilocybin and other psychedelics: coloradospringscriminaldefense.net, Colorado Public Radio, Colorado General Assembly | (.gov)

• New Mexico's Medical Psilocybin Act: New Mexico Department of Health, New Mexico Legislature (.gov), Asurint 

Federal perspective

• Psychedelics remain Schedule I substances:, DEA Diversion Control (.gov), Drexel

• Bipartisan interest in psychedelic drug reform: Marijuana Moment, Psychedelic Alpha, Marijuana Moment 

Decriminalization

• Cities that have decriminalized psychedelics:, Wikipedia, microdose.buzz 

Public opinion

• Public opinion surveys on psychedelic reform: Ipsos, prri.org 

Benefits and risks

• Research on MDMA for PTSD (MAPS): Multidisciplinary Association for Psychedelic Studies – MAPS, Psychedelic Support, NPR

• Psilocybin depression & addiction research: UTHealth Houston, McGuireWoods, National Institute on Drug Abuse (NIDA) (.gov)

• Potential risks and challenges: www.ludlowcub.com, Route Fifty 

Regulatory and research efforts

• Regulating psychedelic therapy and therapist licensing: Reason Foundation, Phillips Lytle LLP, Psychedelic Support

• FDA approval of synthetic psychedelics: National Institute on Drug Abuse (NIDA) (.gov), Reuters

• Ongoing research: American Psychological Association (APA), ScienceDirect.com, National Institutes of Health (NIH) | (.gov)